Stonebridge Capital Advisors’s Sanofi SNY Stock Holding History

Stonebridge Capital Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21	Closed	-$1.13K	–	756
2023 Q3	$1.13K	Sell	21 -21	-50%	-$1.12K	﹤0.01%	851
2023 Q2	$2.26K	Hold	42	–	–	﹤0.01%	805
2023 Q1	$2.29K	Hold	42	–	–	﹤0.01%	801
2022 Q4	$2.03K	Hold	42	–	–	﹤0.01%	803
2022 Q3	$2K	Buy	+42	New	+$1.87K	﹤0.01%	825
2022 Q2	–	Sell	-145	Closed	-$7K	–	1066
2022 Q1	$7K	Hold	145	–	–	﹤0.01%	731
2021 Q4	$7K	Hold	145	–	–	﹤0.01%	701
2021 Q3	$7K	Sell	145 -38	-21%	-$1.93K	﹤0.01%	683
2021 Q2	$10K	Hold	183	–	–	﹤0.01%	620
2021 Q1	$9K	Buy	+183	New	+$8.79K	﹤0.01%	659
2020 Q3	–	Sell	-145	Closed	-$7K	–	624
2020 Q2	$7K	Hold	145	–	–	﹤0.01%	538
2020 Q1	$6K	Hold	145	–	–	﹤0.01%	543
2019 Q4	$7K	Sell	145 -755	-84%	-$35.4K	﹤0.01%	604
2019 Q3	$42K	Sell	900 -48	-5%	-$2.07K	0.01%	346
2019 Q2	$41K	Buy	+948	New	+$40.3K	0.01%	353

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Stonebridge Capital Advisors's SNY Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Sanofi (SNY) in Q4 2023, closing a stake of 21 shares — an estimated $1.13K sold.

Stonebridge Capital Advisors first reported a position in SNY in Q2 2019 and held it in 15 quarters. The position peaked at $42K in Q3 2019. 709 funds tracked by Wall St. Rank hold SNY as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Sanofi position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 21 Sanofi shares in Q4 2023, an estimated $1.13K.
Stonebridge Capital Advisors first reported a position in Sanofi in Q2 2019 and held it in 15 quarters.
Stonebridge Capital Advisors's Sanofi position peaked at $42K in Q3 2019.
709 funds tracked by Wall St. Rank held Sanofi as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.